New Evidence from Randomized Clinical Trial by Barnabas and Colleagues
Posted: 1/21/2022 (CSDE in the News)
CSDE Affiliate and Associate Professor of Global Health Ruanne Barnabas and her co-authors recently published a study of an easy-to-administer anti-SARS-CoV-2 treatment’s efficacy on progression from early asymptomatic SARS-CoV-2 infection to symptomatic COVID-19. You can read the full study HERE. The authors find that this antibody treatment reduced the incidence of symptomatic COVID-19 cases within their sample, relative to the placebo comparison.